If a breast cancer is ER-negative, PR-negative and HER2-negative, it is then known as Triple Negative Breast Cancer (TNBC). TNBC tends to be more aggressive than other types of breast cancer. Because this type of breast cancer is identified for what it is not (not hormone receptive, not HER2 receptive) and it is unknown for sure what fuels this type of breast cancer, there are fewer effective treatments available. However, there are three approved targeted therapies for TNBC currently and more are in clinical trials now. However, rates of triple-negative breast cancer account for about 30% of cases in Black women, and it is about two times more common in Black women than in white women. We are working to change these statistics.
Start taking action today for TNBC care equity. Here are some TNBC Resources to learn more:
Twins changing the trajectory cancer has on their family #shorts
Being misdiagnosed 2x #shorts
I was promised it was not going to be cancer #shorts
A TNBC diagnosis is hard to digest #shorts
When they first told me everything moved so fast #shorts
Learning and clinical trials #shorts